FDA — authorised 7 June 2000
- Application: BLA020986
- Marketing authorisation holder: NOVO NORDISK INC
- Status: supplemented
🇺🇸 Aspart in United States
FDA authorised Aspart on 7 June 2000
Marketing authorisations
FDA — authorised 1 November 2001
- Application: BLA021172
- Marketing authorisation holder: NOVO NORDISK INC
- Status: supplemented
FDA
- Status: approved
Aspart in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is Aspart approved in United States?
Yes. FDA authorised it on 7 June 2000; FDA authorised it on 1 November 2001; FDA has authorised it.
Who is the marketing authorisation holder for Aspart in United States?
NOVO NORDISK INC holds the US marketing authorisation.